Trial Profile
A Phase 4, Randomized, Double-Blind, Multi-Center, Comparator Study Evaluating the Safety and Efficacy of Dexmedetomidine Compared to IV Midazolam in ICU Subjects Requiring Greater Than Twenty-Four Hours of Continuous Sedation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Midazolam
- Indications Sedation
- Focus Therapeutic Use
- Sponsors Hospira
- 25 Jul 2015 New trial record